DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action

During the COVID-19 pandemic, drug repurposing represented an effective strategy to obtain quick answers to medical emergencies. Based on previous data on methotrexate (MTX), we evaluated the anti-viral activity of several DHFR inhibitors in two cell lines. We observed that this class of compounds s...

Full description

Bibliographic Details
Main Authors: Daniela Iaconis, Francesca Caccuri, Candida Manelfi, Carmine Talarico, Antonella Bugatti, Federica Filippini, Alberto Zani, Rubina Novelli, Maria Kuzikov, Bernhard Ellinger, Philip Gribbon, Kristoffer Riecken, Francesca Esposito, Angela Corona, Enzo Tramontano, Andrea Rosario Beccari, Arnaldo Caruso, Marcello Allegretti
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:Viruses
Subjects:
Online Access:https://www.mdpi.com/1999-4915/15/5/1128
_version_ 1797598109372514304
author Daniela Iaconis
Francesca Caccuri
Candida Manelfi
Carmine Talarico
Antonella Bugatti
Federica Filippini
Alberto Zani
Rubina Novelli
Maria Kuzikov
Bernhard Ellinger
Philip Gribbon
Kristoffer Riecken
Francesca Esposito
Angela Corona
Enzo Tramontano
Andrea Rosario Beccari
Arnaldo Caruso
Marcello Allegretti
author_facet Daniela Iaconis
Francesca Caccuri
Candida Manelfi
Carmine Talarico
Antonella Bugatti
Federica Filippini
Alberto Zani
Rubina Novelli
Maria Kuzikov
Bernhard Ellinger
Philip Gribbon
Kristoffer Riecken
Francesca Esposito
Angela Corona
Enzo Tramontano
Andrea Rosario Beccari
Arnaldo Caruso
Marcello Allegretti
author_sort Daniela Iaconis
collection DOAJ
description During the COVID-19 pandemic, drug repurposing represented an effective strategy to obtain quick answers to medical emergencies. Based on previous data on methotrexate (MTX), we evaluated the anti-viral activity of several DHFR inhibitors in two cell lines. We observed that this class of compounds showed a significant influence on the virus-induced cytopathic effect (CPE) partly attributed to the intrinsic anti-metabolic activity of these drugs, but also to a specific anti-viral function. To elucidate the molecular mechanisms, we took advantage of our EXSCALATE platform for in-silico molecular modelling and further validated the influence of these inhibitors on nsp13 and viral entry. Interestingly, pralatrexate and trimetrexate showed superior effects in counteracting the viral infection compared to other DHFR inhibitors. Our results indicate that their higher activity is due to their polypharmacological and pleiotropic profile. These compounds can thus potentially give a clinical advantage in the management of SARS-CoV-2 infection in patients already treated with this class of drugs.
first_indexed 2024-03-11T03:14:41Z
format Article
id doaj.art-b7bacb79c72b47389e3aeb9d63d3ca35
institution Directory Open Access Journal
issn 1999-4915
language English
last_indexed 2024-03-11T03:14:41Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series Viruses
spelling doaj.art-b7bacb79c72b47389e3aeb9d63d3ca352023-11-18T03:39:25ZengMDPI AGViruses1999-49152023-05-01155112810.3390/v15051128DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of ActionDaniela Iaconis0Francesca Caccuri1Candida Manelfi2Carmine Talarico3Antonella Bugatti4Federica Filippini5Alberto Zani6Rubina Novelli7Maria Kuzikov8Bernhard Ellinger9Philip Gribbon10Kristoffer Riecken11Francesca Esposito12Angela Corona13Enzo Tramontano14Andrea Rosario Beccari15Arnaldo Caruso16Marcello Allegretti17EXSCALATE, Dompé Farmaceutici SpA, Via Tommaso De Amicis, 95, 80131 Napoli, ItalySection of Microbiology Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyEXSCALATE, Dompé Farmaceutici SpA, Via Tommaso De Amicis, 95, 80131 Napoli, ItalyEXSCALATE, Dompé Farmaceutici SpA, Via Tommaso De Amicis, 95, 80131 Napoli, ItalySection of Microbiology Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalySection of Microbiology Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalySection of Microbiology Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyDompè Famaceutici SpA, Via Campo di Pile snc, 67100 L’Aquila, ItalyFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Schnackenburgallee 114, 22525 Hamburg, GermanyFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Schnackenburgallee 114, 22525 Hamburg, GermanyFraunhofer Institute for Translational Medicine and Pharmacology ITMP, Schnackenburgallee 114, 22525 Hamburg, GermanyResearch Department Cell and Gene Therapy, Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, GermanyDepartment of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria SS554, 09042 Monserrato (CA), ItalyDepartment of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria SS554, 09042 Monserrato (CA), ItalyDepartment of Life and Environmental Sciences, University of Cagliari, Cittadella Universitaria SS554, 09042 Monserrato (CA), ItalyEXSCALATE, Dompé Farmaceutici SpA, Via Tommaso De Amicis, 95, 80131 Napoli, ItalySection of Microbiology Department of Molecular and Translational Medicine, University of Brescia, 25123 Brescia, ItalyDompè Famaceutici SpA, Via Campo di Pile snc, 67100 L’Aquila, ItalyDuring the COVID-19 pandemic, drug repurposing represented an effective strategy to obtain quick answers to medical emergencies. Based on previous data on methotrexate (MTX), we evaluated the anti-viral activity of several DHFR inhibitors in two cell lines. We observed that this class of compounds showed a significant influence on the virus-induced cytopathic effect (CPE) partly attributed to the intrinsic anti-metabolic activity of these drugs, but also to a specific anti-viral function. To elucidate the molecular mechanisms, we took advantage of our EXSCALATE platform for in-silico molecular modelling and further validated the influence of these inhibitors on nsp13 and viral entry. Interestingly, pralatrexate and trimetrexate showed superior effects in counteracting the viral infection compared to other DHFR inhibitors. Our results indicate that their higher activity is due to their polypharmacological and pleiotropic profile. These compounds can thus potentially give a clinical advantage in the management of SARS-CoV-2 infection in patients already treated with this class of drugs.https://www.mdpi.com/1999-4915/15/5/1128COVID-19drug repurposingmethotrexateEXSCALATEvirtual screeningmolecular docking
spellingShingle Daniela Iaconis
Francesca Caccuri
Candida Manelfi
Carmine Talarico
Antonella Bugatti
Federica Filippini
Alberto Zani
Rubina Novelli
Maria Kuzikov
Bernhard Ellinger
Philip Gribbon
Kristoffer Riecken
Francesca Esposito
Angela Corona
Enzo Tramontano
Andrea Rosario Beccari
Arnaldo Caruso
Marcello Allegretti
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
Viruses
COVID-19
drug repurposing
methotrexate
EXSCALATE
virtual screening
molecular docking
title DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
title_full DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
title_fullStr DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
title_full_unstemmed DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
title_short DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action
title_sort dhfr inhibitors display a pleiotropic anti viral activity against sars cov 2 insights into the mechanisms of action
topic COVID-19
drug repurposing
methotrexate
EXSCALATE
virtual screening
molecular docking
url https://www.mdpi.com/1999-4915/15/5/1128
work_keys_str_mv AT danielaiaconis dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT francescacaccuri dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT candidamanelfi dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT carminetalarico dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT antonellabugatti dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT federicafilippini dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT albertozani dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT rubinanovelli dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT mariakuzikov dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT bernhardellinger dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT philipgribbon dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT kristofferriecken dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT francescaesposito dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT angelacorona dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT enzotramontano dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT andrearosariobeccari dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT arnaldocaruso dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction
AT marcelloallegretti dhfrinhibitorsdisplayapleiotropicantiviralactivityagainstsarscov2insightsintothemechanismsofaction